NCT02615743.

Trial name or title	Asthma Controller Adherence After Hospitalization
Methods	Open‐label, parallel‐group randomised
Participants	Unlimited text messaging plan Prescription for 1 of the following metered dose inhalers for daily use: Flovent (fluticasone), QVAR (budesonide), Seretide (fluticasone‐salmeterol), Advair MDI (fluticasone‐salmeterol) or Dulera (mometasone‐formoterol) Primary care received at 1 of 3 urban CHOP primary care practices (Karabots, South Philadelphia or Cobbs Creek)
Interventions	Daily text message reminders or control
Outcomes	Feasibility; acceptability; adherence
Starting date	December 2015
Contact information
Notes	https://clinicaltrials.gov/ct2/show/NCT02615743